Loeb Partners Corp’s Novartis NVS Stock Holding History

Loeb Partners Corp’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-335	Closed	-$30K	–	94
2019 Q1	$30K	Sell	335 -11,997	-97%	-$963K	0.62%	44
2018 Q4	$948K	Hold	12,332	–	–	0.44%	59
2018 Q3	$953K	Sell	12,332 -13,782	-53%	-$1.02M	0.35%	63
2018 Q2	$1.77M	Buy	26,114 +14,173	+119%	+$978K	0.45%	65
2018 Q1	$866K	Buy	11,941 +669	+6%	+$50.9K	0.38%	66
2017 Q4	$848K	Hold	11,272	–	–	0.25%	83
2017 Q3	$867K	Hold	11,272	–	–	0.27%	82
2017 Q2	$843K	Sell	11,272 -55	-0.5%	-$3.9K	0.24%	93
2017 Q1	$754K	Hold	11,327	–	–	0.23%	96
2016 Q4	$739K	Buy	+11,327	New	+$735K	0.25%	90
2014 Q4	–	Sell	-58,953	Closed	-$4.97M	–	187
2014 Q3	$4.97M	Sell	58,953 -3,683	-6%	-$298K	1.65%	14
2014 Q2	$5.08M	Buy	62,636 +29,853	+91%	+$2.35M	1.54%	15
2014 Q1	$2.5M	Sell	32,783 -4,296	-12%	-$313K	0.84%	38
2013 Q4	$2.67M	Sell	37,079 -3,348	-8%	-$233K	0.85%	34
2013 Q3	$2.78M	Buy	+40,427	New	+$2.67M	0.94%	28

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Loeb Partners Corp's NVS Position: Q2 2019 in Review

Loeb Partners Corp sold out of Novartis (NVS) in Q2 2019, closing a stake of 335 shares — an estimated $30K sold.

Loeb Partners Corp first reported a position in NVS in Q3 2013 and held it in 15 quarters. The position peaked at $5.08M in Q2 2014. 1,094 funds tracked by Wall St. Rank hold NVS as of Q2 2019.

Loeb Partners Corp reported no remaining Novartis position as of Q2 2019 after selling out during the quarter.
Loeb Partners Corp sold 335 Novartis shares in Q2 2019, an estimated $30K.
Loeb Partners Corp first reported a position in Novartis in Q3 2013 and held it in 15 quarters.
Loeb Partners Corp's Novartis position peaked at $5.08M in Q2 2014.
1,094 funds tracked by Wall St. Rank held Novartis as of Q2 2019.

Based on Loeb Partners Corp's 13F filing for Q2 2019.